United States

People: Compugen Ltd (CGEN.OQ)

CGEN.OQ on NASDAQ Stock Exchange Global Market

16 Aug 2019
Change (% chg)

$0.25 (+7.06%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Sekhri, Paul 

Mr. Paul Jai Sekhri has been appointed Director and Chairman of the Board at Compugen Ltd. effective October 2, 2017. His work experience includes the following roles: Chairman of the Board of Supervisory Directors of Pharming Group NV (from May 2016), Chief Executive Officer of Lycera Corp., Senior Vice President, Integrated Care at Sanofi, Group Executive Vice President, Global Business Development and Chief Strategy Officer at Teva Pharmaceutical Industries Ltd., has held positions in small biopharmaceutical companies, large and small pharmaceutical companies and venture capital/private equity firms, including TPG, Cerimon Pharmaceuticals, Ariad Pharmaceuticals and Novartis AG. Mr. Sekhri has over 30 years of operational experience in the life sciences sector with in-depth knowledge of multinational pharmaceutical and biotechnology markets and products. He holds a Bachelor of Science degree in Zoology from University of Maryland and has completed postgraduate studies in Clinical Anatomy and Neuroscience at School of Medicine, University of Maryland.

Basic Compensation

Total Annual Compensation, --
Restricted Stock Awards, --
Long-Term Incentive Plans, --
All Other, --
Fiscal Year Total, --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --